论文部分内容阅读
目的了解心力衰竭诊治现状,发现诊治环节中的不足,改进诊治现状。方法利用单病种质量控制指标如导致心力衰竭的病因、心功能评价、住院后24小时及出院后应用药物治疗的情况等对心力衰竭诊治进行分析。结果导致心力衰竭的病因中冠心病最多,占53.73%。左室射血分数(LVEF)56.14±14.07%,其中低于50%的患者42例(31.34%),大于50%患者92例(68.66%)。住院期间未应用ACEI/ARB患者26.12%、β受体阻滞剂30.60%、醛固酮类药物40.30%。出院患者有35.07%患者未应用β受体阻滞剂,31.34%患者未应用ACEI/ARB,49.25%患者未应用醛固酮类药物。结论在目前的心力衰竭救治环节中仍存在着心功能评估不全面、能改善预后的药物应用不足以及干预措施适应症评估和应用不足等问题有待改进。
Objective To understand the status quo of diagnosis and treatment of heart failure, find the shortcomings in diagnosis and treatment, and improve the status of diagnosis and treatment. Methods The diagnosis and treatment of heart failure were analyzed using quality control indicators of single disease, such as the etiology of heart failure, cardiac function evaluation, 24 hours after hospitalization and medication after discharge. The leading cause of heart failure in coronary heart disease the most, accounting for 53.73%. The left ventricular ejection fraction (LVEF) was 56.14 ± 14.07%, of which 42 (31.34%) were less than 50% and 92 (68.66%) were more than 50%. 26.12% of patients with ACEI / ARB, 30.60% of β-blockers and 40.30% of aldosterone were not used during hospitalization. 35.07% discharged patients did not use β-blockers, 31.34% did not use ACEI / ARB, 49.25% did not use aldosterone. Conclusion There are still some problems in the current treatment of heart failure, such as incomplete assessment of cardiac function, inadequate application of drugs that can improve the prognosis, and inadequate assessment and application of intervention indications.